Market Cap 13.82B
Revenue (ttm) 2.88B
Net Income (ttm) 1.20B
EPS (ttm) N/A
PE Ratio 12.64
Forward PE 11.36
Profit Margin 41.53%
Debt to Equity Ratio 0.05
Volume 740,100
Avg Vol 416,348
Day's Range N/A - N/A
Shares Out 44.91M
Stochastic %K 18%
Beta 0.64
Analysts Strong Sell
Price Target $406.17

Latest News on UTHR

The Zen Ten - My Top Picks For 2025

Dec 29, 2024, 4:25 PM EST - 2 months ago

The Zen Ten - My Top Picks For 2025

AAPL BBW IBKR INTU META NVDA TSM


United Therapeutics Shares Thrive

Aug 30, 2024, 12:02 PM EDT - 6 months ago

United Therapeutics Shares Thrive


United Therapeutics: Economics Support Compounding Ability

Aug 19, 2024, 10:00 PM EDT - 7 months ago

United Therapeutics: Economics Support Compounding Ability


Big Money Elevating United Therapeutics

Jun 28, 2024, 10:36 AM EDT - 9 months ago

Big Money Elevating United Therapeutics